Correlation Between Reviva Pharmaceuticals and Roivant Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Roivant Sciences, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Roivant Sciences.

Diversification Opportunities for Reviva Pharmaceuticals and Roivant Sciences

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Reviva and Roivant is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Roivant Sciences go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Roivant Sciences

Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to generate 9.66 times more return on investment than Roivant Sciences. However, Reviva Pharmaceuticals is 9.66 times more volatile than Roivant Sciences. It trades about 0.05 of its potential returns per unit of risk. Roivant Sciences is currently generating about 0.15 per unit of risk. If you would invest  262.00  in Reviva Pharmaceuticals Holdings on August 29, 2024 and sell it today you would lose (243.00) from holding Reviva Pharmaceuticals Holdings or give up 92.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy13.74%
ValuesDaily Returns

Reviva Pharmaceuticals Holding  vs.  Roivant Sciences

 Performance 
       Timeline  
Reviva Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Roivant Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roivant Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Roivant Sciences is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Reviva Pharmaceuticals and Roivant Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reviva Pharmaceuticals and Roivant Sciences

The main advantage of trading using opposite Reviva Pharmaceuticals and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.
The idea behind Reviva Pharmaceuticals Holdings and Roivant Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments